<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Saina Bijanzadeh – CV</title>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700&display=swap" rel="stylesheet">
<link rel="stylesheet" href="style.css">
</head>
<body>
    <header>
        <h1>Saina Bijanzadeh</h1>
        <p>Email: <a href="mailto:bijanzadehsaina@gmail.com">bijanzadehsaina@gmail.com</a> | Phone: +989394133378 | <a href="#">LinkedIn</a> | <a href="#">ResearchGate</a></p>
        <p class="research-interests">Biomedical Signals & AI • Nanoparticle-Based Drug Delivery • Neuroinflammation & Neurodegenerative Therapeutics</p>
    </header>

    <main>
        <section id="education">
            <h2>Education</h2>
            <div class="card">
                <h3>M.Sc., Inorganic Chemistry</h3>
                <p>University of Tehran, Iran — Oct 2021 – Feb 2024</p>
                <p><strong>GPA:</strong> 17.68/20 (3.54/4.0) | <strong>Thesis Grade:</strong> 20/20</p>
                <p><strong>Thesis:</strong> Design, Synthesis, and Characterization of Ceria Nanoparticles for Drug Delivery in Neurodegenerative Diseases</p>
            </div>
            <div class="card">
                <h3>B.Sc., Pure Chemistry</h3>
                <p>University of Tehran, Iran — Oct 2017 – Sept 2021</p>
                <p><strong>GPA:</strong> 16.4/20 (3.28/4.0)</p>
                <p><strong>Project:</strong> Metallic Chelating Ligands & MOFs for Parkinson’s Disease</p>
            </div>
        </section>

        <section id="research">
            <h2>Research Experience</h2>
            <div class="card">
                <h3>Research Assistant — University of Tehran</h3>
                <p>Oct 2021 – Present</p>
                <ul>
                    <li>Developed chitosan-coated nanoceria for controlled drug release of levodopa for Parkinson’s Disease.</li>
                    <li>Developed a chitosan-sandwiched nanoceria carrier for levodopa, placing the drug between protective layers to reduce oxidation.</li>
                    <li>Collaborating internationally on MOFs for advanced drug carriers.</li>
                </ul>
            </div>
            <div class="card">
                <h3>Independent Projects — Tehran, Iran</h3>
                <p>Oct 2024 – Present</p>
                <ul>
                    <li>AI-driven optimization of chitosan-coated nanoceria for Parkinson’s therapy (sole author; preprint in preparation).</li>
                    <li>Computational project linking EEG-based neuroinflammation to nanoparticle therapy (co-author; preprint in preparation).</li>
                </ul>
            </div>
        </section>

        <section id="skills">
            <h2>Skills</h2>
            <ul>
                <li><strong>Research & Technical:</strong> Nanoparticle synthesis, drug delivery systems, UV-Vis, FT-IR, PXRD, TEM, SEM, DLS, bioinorganic chemistry</li>
                <li><strong>Programming:</strong> Python (AI & data analysis), C++, ChemDraw, Origin</li>
                <li><strong>Design & Visualization:</strong> Illustrator, Photoshop, Premiere Pro, Capcut, BioRender, Figma</li>
            </ul>
        </section>

        <section id="publications">
            <h2>Publications (In Preparation)</h2>
            <ul>
                <li>First Author – Ceria Nanoparticles for Drug Delivery in Neurodegenerative Diseases (Target: Biomaterials Science)</li>
                <li>First Author – Review on Nose-to-Brain Drug Delivery of Levodopa (Target: Journal of Controlled Release)</li>
                <li>Sole Author – AI-Driven Optimization of Chitosan-Coated Nanoceria (Preprint)</li>
                <li>Co-Author – EEG & Nanoparticle Therapy Framework (Preprint)</li>
            </ul>
        </section>
    </main>

    <footer>
        <p>&copy; 2025 Saina Bijanzadeh</p>
    </footer>
</body>
</html>
